cyclosporine has been researched along with Eczema in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (14.71) | 18.2507 |
2000's | 4 (11.76) | 29.6817 |
2010's | 12 (35.29) | 24.3611 |
2020's | 13 (38.24) | 2.80 |
Authors | Studies |
---|---|
Bjerregård Øland, C; Gutermuth, J; Pink, AE; Soldbro, L; Weidinger, S; Worm, M | 1 |
Balogh, EA; Feldman, SR; Sahni, VN; Strowd, LC | 1 |
Arents, B; Aszodi, N; Avila Valle, G; Barbarot, S; Bieber, T; Brough, HA; Calzavara Pinton, P; Christen-Zäch, S; Deleuran, M; Dittmann, M; Dressler, C; Fink-Wagner, AH; Flohr, C; Fosse, N; Gáspár, K; Gerbens, L; Gieler, U; Girolomoni, G; Gregoriou, S; Kinberger, M; Mortz, CG; Nast, A; Nygaard, U; Redding, M; Rehbinder, EM; Ring, J; Rossi, M; Serra-Baldrich, E; Simon, D; Szalai, ZZ; Szepietowski, JC; Torrelo, A; Werfel, T; Wollenberg, A | 1 |
Aw, D; Chandran, NS; Choi, E; Cook, A; Martin, A; Phuan, C; Yang, S | 1 |
Jang, YJ; Kim, KH; Kim, KJ; Park, EJ; Yoon, JH | 1 |
Baker, C; Charlton, O; Foley, P; Phan, K; Smith, SD | 1 |
Abasq, C; Barbarot, S; Bekel, L; Bessis, D; Bonniaud, B; Bouzille, G; Chambrelan, E; Delaunay, J; Droitcourt, C; Du Thanh, A; Dupuy, A; Kupfer, I; Mahé, E; Mallet, S; Maruani, A; Miquel, J; Phan, A; Poizeau, F; Puzenat, E; Raison-Peyron, N | 1 |
Garland, T; Grindlay, DJC; Harman, KE; Olabi, B; Rogers, NK; Worboys, S | 1 |
Jaworek, A; Jaworek, M; Matusiak, Ł; Szafraniec, K; Szepietowski, JC; Wojas-Pelc, A | 1 |
Abraham, S; Binnmyr, J; Brockow, K; Flohr, C; Halken, S; Heratizadeh, A; Irvine, AD; Mortz, CG; Muraro, A; Schmid-Grendelmeier, P; Schmitt, J; Siegels, D; Van der Poel, LA; Weidinger, S; Werfel, T | 1 |
Bennett, M; Bourke, J; Bowe, S; Kiely, L; Murphy, M; O'Connor, C | 1 |
Augustin, M; Cabral, C; Ihle, P; Kienitz, C; Pittrow, D; Theobald, K; Zietze, HA | 1 |
Oosterhaven, JAF; Schuttelaar, MLA | 1 |
Bercovitch, L; Drucker, AM | 1 |
Cohen, DE; Miller, K; Stein, JA; Wu, TP | 1 |
Bygum, A; Winther, AH | 1 |
Gaffin, JM; Kanchongkittiphon, W; Phipatanakul, W | 1 |
Christoffers, WA; Coenraads, PJ; de Bruin-Weller, MS; Politiek, K; Schuttelaar, ML; van der Schaft, J | 1 |
Deleuran, MS; Hjuler, KF; Iversen, L; Jakobsen, L; Olsen, M; Riis, JL; Vestergaard, C | 1 |
Aberer, W; Augustin, M; Bauer, A; Fölster-Holst, R; Luger, T; Meurer, M; Oertel, R; Schäkel, K; Schmitt, J | 1 |
Duffy, S; Griffin, S; Ingram, JR; Paulden, M; Rodgers, M; Sculpher, M; Slack, R; Woolacott, N | 1 |
Andersen, KE; Otkjaer, A; Paulsen, E | 1 |
Chavarría Mur, E; Mauleón Fernández, C; Silvente San Nicasio, C; Valdivielso Ramos, M | 1 |
Alvarez-López, M; Casas Asuncion, E; Moreno, JC; Puya, R; Velez, A | 1 |
Bowers, PW; Julian, CG | 1 |
Abboud, M; Locatelli, F; Muwakkit, S; Razzouk, B; Wilimas, J | 1 |
Chaudhuri, PR; Pilling, RF; Sabri, K | 1 |
Bruijnzeel-Koomen, C; de Bruin-Weller, M; Hijnen, DJ; Knol, E | 1 |
Eriksson, E; Erkko, P; Granlund, H; Reitamo, S | 1 |
Erkko, P; Granlund, H; Reitamo, S | 2 |
Balguerie, X; Boullie, MC; Joly, P; Lauret, P; Tanasescu, S; Thomine, E; Tron, P; Vannier, JP | 1 |
Menné, T; Petersen, CS | 1 |
5 review(s) available for cyclosporine and Eczema
Article | Year |
---|---|
The evolving atopic dermatitis management landscape.
Topics: Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Eczema; Humans; Janus Kinase Inhibitors | 2022 |
What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies.
Topics: Acetates; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Therapy; Child; Complementary Therapies; Cyclopropanes; Cyclosporine; Cytochrome P-450 CYP1A2 Inducers; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Naltrexone; Narcotic Antagonists; Omalizumab; Placebo Effect; Probiotics; Quinolines; Sulfides; Ustekinumab; Vitamin D | 2020 |
Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatitis, Atopic; Eczema; Humans | 2021 |
Child with atopic dermatitis.
Topics: Administration, Topical; Animals; Antigens, Dermatophagoides; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Desensitization, Immunologic; Eczema; Edema; Humans; Immunoglobulin E; Male; Pyroglyphidae; Tacrolimus | 2015 |
Alitretinoin for the treatment of severe chronic hand eczema.
Topics: Algorithms; Alitretinoin; Azathioprine; Chronic Disease; Cyclosporine; Dermatologic Agents; Eczema; Hand Dermatoses; Humans; Immunosuppressive Agents; Psychometrics; PUVA Therapy; Quality of Life; Quality-Adjusted Life Years; Tretinoin | 2010 |
5 trial(s) available for cyclosporine and Eczema
Article | Year |
---|---|
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7).
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Double-Blind Method; Eczema; Glucocorticoids; Humans; Severity of Illness Index; Treatment Outcome | 2022 |
Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
Topics: Adolescent; Adult; Aged; Alitretinoin; Chronic Disease; Cyclosporine; Dermatologic Agents; Eczema; Female; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Patient Reported Outcome Measures; Pregnancy; Prospective Studies; Psychometrics; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index; Young Adult | 2018 |
Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Double-Blind Method; Eczema; Female; Humans; Male; Prednisolone; Statistics as Topic; Treatment Outcome; Young Adult | 2010 |
Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Creatinine; Cyclosporine; Double-Blind Method; Drug Tolerance; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Recurrence; Treatment Outcome | 1996 |
Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Cyclosporine; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Male; Middle Aged; Quality of Life | 1997 |
24 other study(ies) available for cyclosporine and Eczema
Article | Year |
---|---|
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
Topics: Adolescent; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Mycophenolic Acid | 2022 |
A clinical trial in children and young people with severe eczema comparing methotrexate with ciclosporin.
Topics: Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Methotrexate | 2023 |
Outcomes of prolonged and low-dose ciclosporin in an Asian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Child; Cyclosporine; Eczema; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2021 |
Efficacy and Safety of Treatment with Oral Alitretinoin and Oral Cyclosporine for Chronic Hand Eczema: A Retrospective Review of 118 Cases.
Topics: Administration, Oral; Alitretinoin; Chronic Disease; Cyclosporine; Dermatologic Agents; Eczema; Hand Dermatoses; Humans; Patient Safety; Retrospective Studies; Skin; Time Factors; Treatment Outcome | 2020 |
Dermatologist attitudes toward ciclosporin use in atopic dermatitis.
Topics: Attitude; Cyclosporine; Dermatitis, Atopic; Dermatologists; Eczema; Humans | 2021 |
Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis.
Topics: Child; Cohort Studies; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Pharmaceutical Preparations | 2020 |
Itch Relief in Atopic Dermatitis: Comparison of Narrowband Ultraviolet B Radiation and Cyclosporine Treatment.
Topics: Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Pruritus; Ultraviolet Therapy | 2020 |
Novel agents for atopic dermatitis in patients over 50 years of age: A case series.
Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Infant; Methotrexate; Treatment Outcome | 2021 |
[Epidemiology and treatment of adult patients with atopic dermatitis : Analysis of longitudinal data of the statutory health insurance scheme].
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Insurance, Health | 2021 |
Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis.
Topics: Child; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Methotrexate | 2018 |
Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Cyclosporine; Dermatologic Agents; Eczema; Female; Humans; Keratoacanthoma; Keratolytic Agents; Keratosis, Actinic; Prurigo; Pruritus; Retrospective Studies | 2013 |
Can median nail dystrophy be an adverse effect of alitretinoin treatment?
Topics: Alitretinoin; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Substitution; Eczema; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Nail Diseases; Nails, Malformed; Time Factors; Treatment Outcome; Tretinoin | 2014 |
Drug survival of cyclosporine in the treatment of hand eczema: a multicentre, daily use study.
Topics: Cyclosporine; Eczema; Female; Hand Dermatoses; Humans; Male; Middle Aged; Netherlands; Off-Label Use; Patch Tests; Retrospective Studies; Treatment Outcome | 2016 |
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, Atopic; Eczema; Female; Follow-Up Studies; Hospitalization; Hospitals; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Myocardial Infarction; Registries; Risk Factors; Young Adult | 2016 |
The coumarin herniarin as a sensitizer in German chamomile [Chamomilla recutita (L.) Rauschert, Compositae].
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Beverages; Cyclosporine; Dermatitis, Allergic Contact; Eczema; Female; Humans; Matricaria; Middle Aged; Patch Tests; Umbelliferones | 2010 |
[Eccema herpeticum].
Topics: Acyclovir; Adrenal Cortex Hormones; Adult; Antiviral Agents; Cyclosporine; Dermatitis, Atopic; Eczema; Herpes Simplex; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; PUVA Therapy; Simplexvirus; Virus Activation | 2012 |
Treatment of severe refractory adult atopic dermatitis with ustekinumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; Female; Humans; Immunosuppressive Agents; Prednisone; Pruritus; Severity of Illness Index; Ultraviolet Therapy; Ustekinumab; Young Adult | 2012 |
Dogger Bank Itch and cyclosporin.
Topics: Administration, Oral; Adult; Cyclosporine; Eczema; Facial Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Seaweed | 2001 |
Report of a child with vitiligo and Evans syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Child, Preschool; Cyclosporine; Eczema; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infections; Male; Milk Hypersensitivity; Prednisone; Rituximab; Salmonella Infections; Syndrome; Thrombocytopenia; Vitiligo; Zidovudine | 2003 |
Non-traumatic sixth nerve palsy in a young patient.
Topics: Abducens Nerve; Abducens Nerve Diseases; Adult; Cyclosporine; Dermatologic Agents; Diplopia; Eczema; Female; Humans; Paralysis | 2005 |
Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Diagnosis, Differential; Eczema; Humans; Immunoglobulin E; Immunosuppressive Agents | 2007 |
Long-term follow-up of eczema patients treated with cyclosporine.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Female; Follow-Up Studies; Hand; Humans; Immunosuppressive Agents; Male; Photosensitivity Disorders | 1998 |
[Eczema-like cutaneous graft versus host disease treated by UV-B therapy in a 2-year-old child].
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Eczema; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Living Donors; Male; Scalp; Ultraviolet Therapy | 1999 |
Cyclosporin A responsive chronic severe vesicular hand eczema.
Topics: Administration, Oral; Aged; Chronic Disease; Cyclosporine; Eczema; Hand Dermatoses; Humans; Male; Severity of Illness Index; Skin Diseases, Vesiculobullous | 1992 |